Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin as adjuvant therapy to improve stone-free rate after ESWL for renal stones
TCTR20230502002Phase 3Unknown
- Sponsor
- Rayong Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silodosin in nephrolithiasis, sponsored by Rayong Hospital. Status: unknown.
02
Drugs
silodosin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on TCTR20230502002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230502002.